BRAF and melanoma: Resistance mechanisms have been studied extensively in BRAF-mutated melanomas and it could be demonstrated that various genetic mechanisms ranging from BRAF gene amplification to alternative driver gene mutations may mediate BRAF inhibitor resistance [37].